{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:19:21Z","timestamp":1787861961227,"version":"build-2784847793"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Government of India Department of Atomic Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bioorg.2024.108093","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:26:24Z","timestamp":1735403184000},"page":"108093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Recent advancements in the quest of benzazoles as anti-Mycobacterium tuberculosis agents"],"prefix":"10.1016","volume":"155","author":[{"given":"Kshitij I.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirjhar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas M.","family":"Dhameliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-6293","authenticated-orcid":false,"given":"Asit K.","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.108093_b0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chom.2011.11.012","article-title":"Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells","volume":"11","author":"Blomgran","year":"2012","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.bioorg.2024.108093_b0010","doi-asserted-by":"crossref","unstructured":"S. Kiazyk, T. Ball, Latent tuberculosis infection: An overview, Canada Commun. Dis. Rep. 43 (2017) 62\u201366. 10.14745\/ccdr.v43i34a01.","DOI":"10.14745\/ccdr.v43i34a01"},{"key":"10.1016\/j.bioorg.2024.108093_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF03256649","article-title":"The role of DOTS in tuberculosis treatment and control","volume":"2","author":"Davies","year":"2003","journal-title":"Am. J. Respir. Med."},{"key":"10.1016\/j.bioorg.2024.108093_b0020","unstructured":"Who |, Global tuberculosis report 2023 2024 (n.d.). accessed September 14."},{"key":"10.1016\/j.bioorg.2024.108093_b0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1741-7015-11-190","article-title":"Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: Clinical and public health benefits and barriers to implementation","volume":"11","author":"Drobniewski","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.bioorg.2024.108093_b0030","unstructured":"World Health Organization (WHO), WHO consolidated guidelines on drug-resistant tuberculosis treatment, (2019). https:\/\/apps.who.int\/iris\/handle\/10665\/311389 (accessed April 4, 2022)."},{"key":"10.1016\/j.bioorg.2024.108093_b0035","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/MJT.0b013e3181c0806d","article-title":"Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: A report from Iran","volume":"18","author":"Baghaei","year":"2011","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.bioorg.2024.108093_b0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/14740338.4.5.821","article-title":"Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy","volume":"4","author":"Di Perri","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bioorg.2024.108093_b0045","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1021\/acs.jmedchem.7b00108","article-title":"Triaryl Benzimidazoles as a New Class of Antibacterial Agents against Resistant Pathogenic Microorganisms","volume":"60","author":"Picconi","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0050","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/jf3053934","article-title":"Synthesis and Antifungal Activity of 2-Chloromethyl-1H-benzimidazole Derivatives against Phytopathogenic Fungi in Vitro","volume":"61","author":"Bin Bai","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/jm950412w","article-title":"Substituted 2,5\u2032-Bi-1H-benzimidazoles: Topoisoraerase I inhibition and cytotoxicity","volume":"39","author":"Kim","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0060","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/jm960547h","article-title":"Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres","volume":"39","author":"Kohara","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0065","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ejmech.2010.01.007","article-title":"Derivatives of benzimidazole pharmacophore: Synthesis, anticonvulsant, antidiabetic and DNA cleavage studies","volume":"45","author":"Shingalapur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0070","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/jm000004e","article-title":"Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors","volume":"43","author":"Kalgutkar","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0075","first-page":"1299","article-title":"Efficacy of albendazole and mebendazole with or without levamisole for ascariasis and trichuriasis, Open Access Maced","volume":"7","author":"Anto","year":"2019","journal-title":"J Med. Sci."},{"key":"10.1016\/j.bioorg.2024.108093_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/290159a0","article-title":"Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase","volume":"290","author":"Fellenius","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.108093_b0085","first-page":"365","article-title":"Recent Advancements on Benzimidazole: A Versatile Scaffold in Medicinal Chemistry, Mini-Reviews","volume":"22","author":"Alzhrani","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejmech.2014.10.058","article-title":"Bioactive thiazole and benzothiazole derivatives","volume":"97","author":"Rouf","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.micres.2013.02.002","article-title":"Marine actinobacterial metabolites: Current status and future perspectives","volume":"168","author":"Manivasagan","year":"2013","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bioorg.2024.108093_b0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"key":"10.1016\/j.bioorg.2024.108093_b0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/518155","article-title":"Therapy for and prevention of traveler\u2019s diarrhea","volume":"45","author":"DuPont","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.108093_b0110","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2174\/1389450118666170711150034","article-title":"Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design","volume":"18","author":"Singh","year":"2017","journal-title":"Curr. Drug Targets."},{"key":"10.1016\/j.bioorg.2024.108093_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17460441.2017.1255604","article-title":"Current challenges in drug discovery for tuberculosis","volume":"12","author":"Kumar","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.108093_b0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2016.08.002","article-title":"Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis","volume":"101","author":"Swaminathan","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioorg.2024.108093_b0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejmech.2018.03.020","article-title":"Drug discovery in tuberculosis. New drug targets and antimycobacterial agents","volume":"150","author":"Campani\u00e7o","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/femsre\/fuz006","article-title":"Mycobacterium tuberculosis infection of host cells in space and time","volume":"43","author":"Bussi","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2024.108093_b0135","first-page":"4638","article-title":"Microwave assisted synthesis of biorelevant benzazoles","volume":"24","author":"Seth","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2014.10.059","article-title":"A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry","volume":"89","author":"Keri","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0145","first-page":"4653","article-title":"Benzoxazole derivatives as promising antitubercular agents","volume":"3","author":"\u0160lachtov\u00e1","year":"2018","journal-title":"Chem. Sel."},{"key":"10.1016\/j.bioorg.2024.108093_b0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","article-title":"Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review","volume":"97","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0155","doi-asserted-by":"crossref","unstructured":"U. Kamal, N.M. Javed, A. Kumar, Biological Potential of Benzoxazole Derivatives: An Updated Review, Asian J. Pharm. Clin. Res. 13 (2020) 28\u201341. 10.22159\/ajpcr.2020.v13i8.37958.","DOI":"10.22159\/ajpcr.2020.v13i8.37958"},{"key":"10.1016\/j.bioorg.2024.108093_b0160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bmc.2009.11.033","article-title":"Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)","volume":"18","author":"Sivendran","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2012.03.033","article-title":"Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents","volume":"53","author":"Patel","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0170","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ml4002248","article-title":"Identification of 1-[4-benzyloxyphenyl)-but-3-enyl]-1H-azoles as new class of antitubercular and antimicrobial agents","volume":"4","author":"Anand","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112010","article-title":"Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity","volume":"188","author":"Sirim","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0180","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2014.06.004","article-title":"Synthesis, antibacterial and antitubercular activities of benzimidazole bearing substituted 2-pyridone motifs","volume":"82","author":"Desai","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1039\/C8MD00389K","article-title":"Design, synthesis, and in vitro biological evaluation of novel benzimidazole tethered allylidenehydrazinylmethylthiazole derivatives as potent inhibitors of Mycobacterium tuberculosis","volume":"10","author":"Surineni","year":"2019","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bioorg.2024.108093_b0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/2211352517666190301144054","article-title":"Design, optimization, synthesis and anti-TB screening of benzimidazole derivatives","volume":"18","author":"Panneerselvam","year":"2019","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.bioorg.2024.108093_b0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2015.03.024","article-title":"Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives","volume":"95","author":"Ramprasad","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0200","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1038\/ncomms8659","article-title":"Lansoprazole is an antituberculous prodrug targeting cytochrome bc1","volume":"6","author":"Rybniker","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2024.108093_b0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tube.2018.06.015","article-title":"Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with Isoniazid and Rifampicin","volume":"111","author":"Corr\u00eaa Barros","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioorg.2024.108093_b0210","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1016\/j.bmc.2017.07.034","article-title":"Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity","volume":"25","author":"Wavhale","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0215","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.bmc.2018.07.049","article-title":"A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity","volume":"26","author":"Chaturvedi","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejmech.2014.04.017","article-title":"Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives","volume":"79","author":"Kalalbandi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0225","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/14756366.2010.548331","article-title":"Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-imidazol-1-yl]-pyridin-3-yl-methanones","volume":"26","author":"Narasimhan","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0230","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/00397911.2020.1725057","article-title":"N-Mannich bases of benzimidazole as a potent antitubercular and antiprotozoal agents: Their synthesis and computational studies","volume":"50","author":"Patel","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2024.108093_b0235","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1016\/j.bmcl.2008.09.096","article-title":"Clubbed [1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis","volume":"18","author":"Gill","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0240","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.drudis.2011.10.024","article-title":"Classification of Scaffold-hopping approaches","volume":"17","author":"Sun","year":"2012","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2024.108093_b0245","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/ml400500e","article-title":"2-(2-Arylphenyl)benzoxazole as a novel anti-inflammatory scaffold: Synthesis and biological evaluation","volume":"5","author":"Seth","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0250","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1039\/C3MD00388D","article-title":"Chakraborti, \u03b1-Aminophosphonates as novel anti-leishmanial chemotypes: Synthesis, biological evaluation, and CoMFA studies","volume":"5","author":"Bhagat","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.108093_b0255","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bioorg.2018.09.023","article-title":"\u03b1-Sulfonamidophosphonates as new anti-mycobacterial chemotypes: Design, development of synthetic methodology, and biological evaluation","volume":"82","author":"Bhagat","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0260","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1016\/j.bmcl.2016.10.082","article-title":"Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads","volume":"26","author":"Tanwar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104538","article-title":"Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents","volume":"107","author":"Dhameliya","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0270","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1021\/jo301793z","article-title":"Hydrogen-bond-driven electrophilic activation for selectivity control: Scope and limitations of fluorous alcohol-promoted selective formation of 1,2-disubstituted benzimidazoles and mechanistic insight for rationale of selectivity","volume":"77","author":"Chebolu","year":"2012","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1039\/C2RA21994H","article-title":"Selectivity Control During the Synthesis of 1,2-Disubstituted Benzimidazoles and Mechanistic Insight to Rationalize Selectivity","volume":"3","author":"Kumar","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.108093_b0280","doi-asserted-by":"crossref","first-page":"10077","DOI":"10.1021\/acs.joc.7b01548","article-title":"Rationalization of benzazole-2-carboxylate versus benzazine-3-one\/benzazine-2,3-dione selectivity switch during cyclocondensation of 2-aminothiophenols\/phenols\/anilines with 1,2-biselectrophiles in aqueous medium","volume":"82","author":"Dhameliya","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0285","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1039\/b710414f","article-title":"\u201cOn water\u201d organic synthesis: a highly efficient and clean synthesis of 2-aryl\/heteroaryl\/styryl benzothiazoles and 2-alkyl\/aryl alkyl benzothiazolines","volume":"9","author":"Chakraborti","year":"2007","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0290","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1039\/C0CC03166F","article-title":"Surfactant mediated oxygen reuptake in water for green aerobic oxidation: mass-spectrometric determination of discrete intermediates to correlate oxygen uptake with oxidation efficiency","volume":"47","author":"Parikh","year":"2011","journal-title":"Chem. Comm."},{"key":"10.1016\/j.bioorg.2024.108093_b0295","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1039\/c2gc36377a","article-title":"\u201c All-water \u201d chemistry of tandem N -alkylation \u2013 reduction \u2013 condensation for synthesis of N -arylmethyl-2-substituted benzimidazoles","volume":"14","author":"Kommi","year":"2012","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0300","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1039\/c3gc37004f","article-title":"\u201cAll-water\u201d one-pot diverse synthesis of 1,2-disubstituted benzimidazoles: hydrogen bond driven \u201cSynergistic Electrophile\u2013Nucleophile dual activation\u201d by water","volume":"15","author":"Kommi","year":"2013","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0305","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1021\/ol060846t","article-title":"Catalyst-Free Conjugated Addition of Thiols to $\u03b1$, $\u03b2$-Unsaturated Carbonyl Compounds in Water","volume":"8","author":"Khatik","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0310","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1021\/ol0611191","article-title":"Catalyst-Free Chemoselective N-tert-Butyloxycarbonylation of Amines in Water","volume":"8","author":"Chankeshwara","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0315","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1039\/c3gc36997h","article-title":"\u201cAll water chemistry\u201d for a concise total synthesis of the novel class anti-anginal drug (RS), (R), and (S)-ranolazine","volume":"15","author":"Kommi","year":"2013","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0320","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/ol302601b","article-title":"Protecting group-Free Concise Synthesis of (RS)\/(S) \u2011 Lubeluzole","volume":"15","author":"Kommi","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0325","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1039\/c3cc42507j","article-title":"Synergistic dual activation catalysis by nanoparticles for epoxide ring opening with phenols","volume":"49","author":"Seth","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.108093_b0330","first-page":"1361","article-title":"Bacterial FtsZ inhibition by benzo[d]imidazole-2-carboxamide derivative with anti-TB activity, Future","volume":"14","author":"Dhameliya","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0335","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/jm200187y","article-title":"The medicinal Chemist\u2019s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates","volume":"54","author":"Roughley","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0340","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd.2018.116","article-title":"Expanding the medicinal chemistry synthetic toolbox","volume":"17","author":"Bostr\u00f6m","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.108093_b0345","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1021\/jm400250p","article-title":"Sustainable Practices in Medicinal Chemistry: Current State and Future Directions","volume":"56","author":"Bryan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0350","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1039\/D2GC03772F","article-title":"GreenMedChem: the challenge in the next decade toward eco-friendly compounds and processes in drug design","volume":"25","author":"Castiello","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0355","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/2211352516666180810101327","article-title":"Synthesis, Screening and Docking Analysis of Novel Benzimidazolium and Benzotriazolium Compounds as Potent Anti Tubercular Agents","volume":"17","author":"Guruvelli","year":"2018","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.bioorg.2024.108093_b0360","first-page":"207","article-title":"Bis-(imidazole\/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity, Future","volume":"12","author":"Antoci","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0365","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1021\/acsmedchemlett.9b00343","article-title":"Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity","volume":"10","author":"Manjunatha","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0370","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.bmc.2011.01.050","article-title":"Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents","volume":"19","author":"Camacho","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0375","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1386207317666140314092412","article-title":"Synthesis and biological evaluation of novel N\u2019-(4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents","volume":"17","author":"Siddiki","year":"2014","journal-title":"Comb. Chem. High through. Screen."},{"key":"10.1016\/j.bioorg.2024.108093_b0380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13065-017-0295-z","article-title":"Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis","volume":"11","author":"Anguru","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2024.108093_b0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2004.10.004","article-title":"Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles","volume":"40","author":"Kazimierczuk","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0390","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s00044-017-1784-2","article-title":"Antituberculosis agents bearing the 1,2-disubstituted benzimidazole scaffold","volume":"26","author":"Yeong","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.108093_b0395","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ejmech.2013.06.025","article-title":"Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters","volume":"93","author":"Yoon","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmech.2019.06.069","article-title":"Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: Antimicrobial evaluation and mechanistic insights","volume":"180","author":"Baartzes","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0405","article-title":"Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives","author":"Yoon","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bioorg.2024.108093_b0410","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1039\/C5RA23282A","article-title":"Novel benzimidazole-oxadiazole hybrid molecules as promising antimicrobial agents","volume":"6","author":"Shruthi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.108093_b0415","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1021\/acs.jmedchem.5b00546","article-title":"Identification of phenoxyalkylbenzimidazoles with antitubercular activity","volume":"58","author":"Chandrasekera","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0420","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bmc.2011.11.020","article-title":"Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity","volume":"20","author":"Gobis","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0425","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2014.10.031","article-title":"Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues","volume":"89","author":"Gobis","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0430","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/acsinfecdis.9b00389","article-title":"Active Benzimidazole derivatives targeting the mmpL3 transporter in Mycobacterium abscessus","volume":"6","author":"Raynaud","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.108093_b0435","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.bmc.2015.03.008","article-title":"Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship","volume":"23","author":"Gobis","year":"2015","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0440","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/jm1012006","article-title":"Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents","volume":"54","author":"Kumar","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0445","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.bmc.2014.03.035","article-title":"Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents","volume":"22","author":"Park","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0450","doi-asserted-by":"crossref","first-page":"9756","DOI":"10.1021\/jm401468w","article-title":"SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents","volume":"56","author":"Awasthi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0455","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejmech.2014.01.039","article-title":"Benzimidazole-based compounds kill Mycobacterium tuberculosis","volume":"75","author":"Gong","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0460","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cmdc.201000490","article-title":"Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB","volume":"6","author":"Pieroni","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.108093_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103774","article-title":"Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation","volume":"99","author":"Jadhavar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0470","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/S0960-894X(02)00697-2","article-title":"Heterocyclic benzazole derivatives with antimycobacterial in vitro activity","volume":"12","author":"Koci","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0475","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1021\/jm800328v","article-title":"Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening","volume":"51","author":"Cho","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0480","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.ejmech.2010.06.031","article-title":"Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles","volume":"45","author":"Patel","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0485","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1021\/jm901112f","article-title":"Searching for new cures for tuberculosis: Design, synthesis, and biological evaluation of 2-methylbenzothiazoles","volume":"52","author":"Huang","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0490","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ardp.201100072","article-title":"Synthesis and comparative study of anti-mycobacterium activity of a novel series of fluoronitrobenzothiazolopyrazoline regioisomers","volume":"345","author":"Hazra","year":"2012","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.108093_b0495","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1039\/C4MD00224E","article-title":"N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: Design, new methods of synthesis and biological evaluation","volume":"5","author":"Shah","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.108093_b0500","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.2174\/0929867323666151106125759","article-title":"Oxazolidinones as anti-tubercular agents: Discovery, development and future perspectives","volume":"22","author":"Jadhavar","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0505","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2016.03.060","article-title":"Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies","volume":"116","author":"Pancholia","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0510","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2018.05.049","article-title":"Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship","volume":"155","author":"Dhameliya","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0515","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1016\/j.bmc.2015.11.017","article-title":"Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-d-ribose 2\u2032-oxidase","volume":"23","author":"Landge","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0520","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2014.02.017","article-title":"Sulfur rich 2-mercaptobenzothiazole and 1,2,3-triazole conjugates as novel antitubercular agents","volume":"76","author":"Mir","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0525","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/ol9907116","article-title":"Novel antimycobacterial benzoxazole alkaloids, from the West Indian Sea whip Pseudopterogorgia elisabethae","volume":"1","author":"Rodr\u00edguez","year":"1999","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0530","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/10070783","article-title":"Highly lipophilic benzoxazoles with potential antibacterial activity","volume":"10","author":"Vin\u0161ov\u00e1","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.108093_b0535","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.bmc.2006.05.030","article-title":"Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles","volume":"14","author":"Vinsova","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0540","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00044-013-0815-x","article-title":"Discovery of new antitubercular agents by combining pyrazoline and benzoxazole pharmacophores\u00a0: Design, synthesis and insights into the binding interactions","volume":"23","author":"Rana","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.108093_b0545","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00044-015-1499-1","article-title":"Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives","volume":"25","author":"Ertan-Bolelli","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.108093_b0550","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1007\/s00044-017-2013-8","article-title":"QSAR of antimycobacterial activity of benzoxazoles by optimal SMILES-based descriptors","volume":"26","author":"Nesm\u011br\u00e1k","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.108093_b0555","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1039\/C7MD00449D","article-title":"Benzisoxazole: A privileged scaffold for medicinal chemistry","volume":"8","author":"Rakesh","year":"2017","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bioorg.2024.108093_b0560","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejmech.2014.09.043","volume":"87","author":"Naidu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0565","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0570","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.bmcl.2016.03.059","article-title":"Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles\/indole)-piperazin-1-yl\/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives","volume":"26","author":"Naidu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0575","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0223-5234(00)00144-6","article-title":"Synthesis and antitubercular activity of 3-aryl substituted-2-(1H(2H) benzotriazol-1(2)-yl)acrylonitriles","volume":"35","author":"Sanna","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0580","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cmdc.201200428","article-title":"Fueling open-source drug discovery: 177 Small-Molecule leads against tuberculosis","volume":"8","author":"Ballell","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.108093_b0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142293","article-title":"Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery","volume":"10","author":"Rebollo-Lopez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.108093_b0590","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1038\/ncomms12581","article-title":"Identification of KasA as the cellular target of an anti-tubercular scaffold","volume":"7","author":"Abrahams","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2024.108093_b0595","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02101-17","article-title":"Synergistic lethality of a binary inhibitor of Mycobacterium tuberculosis kasA","volume":"9","author":"Kumar","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.bioorg.2024.108093_b0600","first-page":"560","article-title":"A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA, Cell","volume":"27","author":"Inoyama","year":"2020","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.108093_b0605","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/acsinfecdis.0c00788","article-title":"Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions","volume":"7","author":"Ginn","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.108093_b0610","article-title":"Indazole to 2-Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial Activity","author":"Sun","year":"2024","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.bioorg.2024.108093_b0615","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11030-012-9385-y","article-title":"Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents","volume":"16","author":"Cihan-\u00dcst\u00fcnda\u011f","year":"2012","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2024.108093_b0620","first-page":"369","article-title":"Indole-based hydrazide-hydrazones and 4-thiazolidinones: Synthesis and evaluation as antitubercular and anticancer agents","volume":"31","author":"Cihan-\u00dcst\u00fcnda\u0287","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0625","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1021\/jm4003878","article-title":"Preliminary structure-Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains","volume":"56","author":"Onajole","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0630","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1021\/acs.jmedchem.6b00415","article-title":"Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection","volume":"59","author":"Stec","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0635","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1021\/acs.jmedchem.7b00582","article-title":"Targeting mycolic acid transport by indole-2-carboxamides for the treatment of Mycobacterium abscessus infections","volume":"60","author":"Kozikowski","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0640","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.bmc.2017.05.015","article-title":"Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity","volume":"25","author":"Franz","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0645","doi-asserted-by":"crossref","first-page":"15497","DOI":"10.1039\/D0RA10728J","article-title":"Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells","volume":"11","author":"Alsayed","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.108093_b0650","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1016\/j.bmc.2008.08.050","article-title":"Synthesis and antituberculosis activity of 5-methyl\/trifluoromethoxy-1H-indole-2,3-dione-3-thiosemicarbazone derivatives","volume":"16","author":"G\u00fczel","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0655","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bmcl.2015.12.049","article-title":"Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones","volume":"26","author":"Velezheva","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0660","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00044-019-02293-w","article-title":"New indole and indazole derivatives as potential antimycobacterial agents","volume":"28","author":"Angelova","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.108093_b0665","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/ml5001933","article-title":"2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis","volume":"5","author":"Naik","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0670","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2015.05.020","article-title":"Synthesis, antimalarial and antitubercular activities of meridianin derivatives","volume":"98","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0675","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2016.12.042","article-title":"Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis","volume":"127","author":"Scalacci","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0680","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/acs.jmedchem.6b01530","article-title":"Amphiphilic indole derivatives as antimycobacterial agents: Structure-activity relationships and membrane targeting properties","volume":"60","author":"Yang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0685","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.108093_b0690","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0695","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1021\/jm500571f","article-title":"Lead optimization of 1,4-azaindoles as antimycobacterial agents","volume":"57","author":"Shirude","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0700","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1128\/AAC.03233-14","article-title":"1,4-azaindole, a potential drug candidate for treatment of tuberculosis","volume":"58","author":"Chatterji","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.108093_b0705","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00583-21","article-title":"Comparative Analysis of Pharmacodynamics in the C3HeB\/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832","volume":"65","author":"Robertson","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.108093_b0710","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.bmcl.2009.04.029","article-title":"A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles","volume":"19","author":"Karthikeyan","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0715","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmech.2015.10.024","article-title":"Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents","volume":"105","author":"Penta","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0720","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s11030-020-10108-z","article-title":"Indole-fused spirochromenes as potential anti-tubercular agents: Design, synthesis and in vitro evaluation","volume":"25","author":"Dogamanti","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2024.108093_b0725","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2011.10.046","article-title":"Synthesis, antimicrobial, antimycobacterial and structure-activity relationship of substituted pyrazolo-, isoxazolo-, pyrimido- and mercaptopyrimidocyclohepta[b]indoles","volume":"47","author":"Yamuna","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0730","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/np3007167","article-title":"Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents","volume":"76","author":"Hwang","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2024.108093_b0735","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1016\/j.bmcl.2009.06.045","article-title":"Functionalized 3-amino-imidazo[1,2-a]pyridines: A novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors","volume":"19","author":"Odell","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0740","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/ml200036r","article-title":"Advent of imidazo[1,2-a]pyridine-3-carboxamides with potent multi- and extended drug resistant antituberculosis activity","volume":"2","author":"Moraski","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0745","first-page":"1","article-title":"Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB","volume":"7","author":"Abrahams","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.108093_b0750","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/ml400088y","article-title":"Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis","volume":"4","author":"Moraski","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.108093_b0755","article-title":"Bactericidal Activity of an Imidazo[1,2-a]pyridine Using a Mouse M. tuberculosis Infection Model","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.108093_b0760","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2024.108093_b0765","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1021\/jm5003606","article-title":"Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent","volume":"57","author":"Kang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108093_b0770","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/acsmedchemlett.6b00330","article-title":"Identification of N-(2-phenoxyethyl)imidazo[1,2-a]pyridine-3-carboxamides as new anti-tuberculosis agents","volume":"7","author":"Lu","year":"2016","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824009982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824009982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T23:22:18Z","timestamp":1740352938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824009982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":154,"alternative-id":["S0045206824009982"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.108093","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in the quest of benzazoles as anti-Mycobacterium tuberculosis agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.108093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108093"}}